COI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 928
EU - Europa 429
AS - Asia 224
AF - Africa 50
OC - Oceania 1
SA - Sud America 1
Totale 1.633
Nazione #
US - Stati Uniti d'America 898
IT - Italia 151
CN - Cina 89
SE - Svezia 65
SG - Singapore 51
TR - Turchia 49
BG - Bulgaria 41
DE - Germania 34
UA - Ucraina 32
CA - Canada 30
GB - Regno Unito 23
AT - Austria 20
CH - Svizzera 18
CI - Costa d'Avorio 17
FI - Finlandia 16
NG - Nigeria 16
SN - Senegal 16
FR - Francia 15
IN - India 15
VN - Vietnam 15
BE - Belgio 10
HK - Hong Kong 4
NL - Olanda 2
AU - Australia 1
BJ - Benin 1
BR - Brasile 1
HR - Croazia 1
JP - Giappone 1
RU - Federazione Russa 1
Totale 1.633
Città #
Ann Arbor 145
Woodbridge 136
Chandler 122
Houston 79
Milan 60
Jacksonville 51
Izmir 43
Sofia 41
Fairfield 38
Ashburn 36
Beijing 36
Florence 32
Ottawa 28
Singapore 25
New York 23
Seattle 20
Vienna 20
Bern 18
Wilmington 18
Abidjan 17
Boardman 17
Nanjing 17
Cambridge 16
Dakar 16
Lagos 16
Lawrence 16
Princeton 16
Santa Clara 16
Serra 15
Pune 13
Marseille 12
Des Moines 11
Brussels 10
Dong Ket 10
Jüchen 9
Lancaster 8
Medford 8
Los Angeles 7
Istanbul 6
Nanchang 6
Rome 6
San Diego 6
Hebei 5
Jiaxing 5
Dearborn 4
Falls Church 4
Hong Kong 4
London 4
Boulder 3
Kunming 3
Norwalk 3
Ogden 3
Shenyang 3
Bremen 2
Changchun 2
Changsha 2
Ho Chi Minh City 2
Redwood City 2
San Francisco 2
Tianjin 2
Torino 2
Toronto 2
Acton 1
Amsterdam 1
Auburn Hills 1
Bacchus Marsh 1
Baotou 1
Berlin 1
Bovisio Masciago 1
Charlotte 1
Chengdu 1
Cotonou 1
Dallas 1
Denver 1
East Hartford 1
Edinburgh 1
Frankfurt am Main 1
Hangzhou 1
Indiana 1
Middlesbrough 1
Mumbai 1
Orange 1
Rio de Janeiro 1
San Jose 1
Shanghai 1
Simi Valley 1
Sunnyvale 1
Taiyuan 1
Tappahannock 1
Tokyo 1
Utrecht 1
Verona 1
Zagreb 1
Totale 1.335
Nome #
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 158
Binding free energy calculations of Adenosine Deaminase inhibitors 147
Evidence for persistent organochlorine pollutants in the human adrenal cortex 140
Molecular Modeling of CYP2D6 complexes and docking of a series of ajmalicine- and quinidine-like inhibitors 131
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 127
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals 120
Classification models for the identification of P-gp inhibitors 102
Prediction of HERG Potassium Channel Affinity by Traditional QSAR and Volsurf Approach 100
QSAR models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the hERG potassium channel inhibition 97
A modeling study of alphaB-crystallin in complex with zinc for investigating the correlation between chaperone-like activity and exposure of hydrophobic surfaces 89
Binding mode of Adenosine Deaminase inhibitors and zinc modeling 88
Theoretical Models for Classification as Cardioprotective Agents of Mitochondrial-KATP Channel Openers (mito-KCOs) Possessing the 4-Spiro-substituted Benzopyranic Structure 80
Structural Studies and Molecular Modeling of alphaB-Crystallin: Effects of Zinc and Temperature 76
Classification models for the risk of drug-induced Torsades de Pointes 73
Bioisosterism, Enantioselectivity and Molecular Modelling of New Effective Substituted 2-Phenyl Adenines and 8-AZA Analogues. Different Binding Modes to A1 Adenosine Receptors 65
Theoretical Models for Classification as Cardioprotective Agents of Mitochondrial-KATP Channel Openers (mito-KCOs) Possessing the 4-Spiro-substituted Benzopyranic Structure 49
Totale 1.642
Categoria #
all - tutte 4.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 15 14 21 9 21 9 28 2
2020/202189 13 2 10 3 8 3 13 8 5 5 4 15
2021/2022145 2 15 0 7 29 23 2 7 6 2 7 45
2022/2023359 24 36 28 33 52 49 1 17 78 2 37 2
2023/2024233 40 36 37 13 26 42 1 8 1 7 8 14
2024/202573 0 21 4 26 22 0 0 0 0 0 0 0
Totale 1.642